Abu Dhabi: SEHA, a subsidiary of PureHealth, will host the Best of ASCO UAE 2024 Conference on June 29-30, 2024, at the Grand Hyatt Abu Dhabi Hotel & Residences Emirates Pearl.
This leading global oncology conference, organized by Tawam Hospital and licensed by the American Society of Clinical Oncology (ASCO), aims to improve cancer care across the medical industry.
The two-day annual meeting will bring together top international, regional, and local experts to discuss recent breakthroughs and advances in cancer treatments.
Recent scientific advances that were on display at the ASCO Annual Meeting 2024, held in Chicago, US, from May 31 to June 5, 2024, will be examined in The Best of ASCO UAE 2024. The meeting will look at the most recent research results, evaluate how they might affect the way that treatment is provided now, and incorporate these discoveries into a clinical setting.
Participants will have a conversation about how these innovative findings can transform the current standard of care and eventually influence how cancer treatments are developed in the future.
SEHA is proud to announce the successful hosting of Best of ASCO, a ground-breaking cancer conference promoting oncology care, according to Dr. Ghanem Ali Al Hassani, Director of Corporate Education. Leading authorities, researchers, medical professionals, and legislators from throughout the world are expected to attend the conference in order to talk about the most recent developments and difficulties in cancer treatment.
The conference’s extensive program, which includes keynote addresses, panel discussions, and interactive workshops, is themed “Towards New Era in Cancer Care.” Prominent speakers will impart their knowledge on state-of-the-art research, novel therapies, and optimal approaches in the prevention, diagnosis, and treatment of cancer.
Dr Al Hassani said that, “Our goal is to bring together the brightest minds in oncology to foster collaboration, share knowledge, and ultimately, improve patient outcomes.”
After a plenary session, the program will go further into issues such as lung cancer, gastrointestinal cancers, genitourinary cancers, advanced breast cancer, and data that could change practice. Interactive sessions on genitourinary, lung, and breast malignancies will also be offered during the conference.
Researchers, oncologists, surgeons, radiologists, doctors, pharmacists, pathologists, allied health professionals, oncology nurses, residents, and medical students are welcome to attend this year’s conference.